SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'OAS'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1BRP_A_RTLA183_0 (RETINOL BINDINGPROTEIN) |
5jd5 | MGS-MILE3 (unculturedbacterium) | 5 / 12 | PHE A 259ALA A 194GLY A 172PHE A 201LEU A 93 | NoneNoneOAS A 169 ( 3.1A)NoneNone | 1.39A | 1brpA-5jd5A:undetectable | 1brpA-5jd5A:20.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1CQE_A_FLPA1650_1 (PROTEIN(PROSTAGLANDIN H2SYNTHASE-1)) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 11 / 12 | ARG A 120VAL A 349LEU A 352TYR A 355LEU A 359TYR A 385TRP A 387ILE A 523GLY A 526ALA A 527LEU A 531 | SCL A 700 (-3.9A)SCL A 700 ( 4.6A)SCL A 700 ( 4.8A)SCL A 700 (-4.3A)NoneNoneNoneSCL A 700 (-3.4A)SCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.31A | 1cqeA-1ebvA:63.1 | 1cqeA-1ebvA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1CQE_B_FLPB2650_1 (PROTEIN(PROSTAGLANDIN H2SYNTHASE-1)) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 11 / 12 | ARG A 120VAL A 349LEU A 352TYR A 355LEU A 359TYR A 385TRP A 387ILE A 523GLY A 526ALA A 527LEU A 531 | SCL A 700 (-3.9A)SCL A 700 ( 4.6A)SCL A 700 ( 4.8A)SCL A 700 (-4.3A)NoneNoneNoneSCL A 700 (-3.4A)SCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.31A | 1cqeB-1ebvA:63.0 | 1cqeB-1ebvA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1EQG_A_IBPA701_1 (PROSTAGLANDIN H2SYNTHASE-1) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 8 / 9 | VAL A 116ARG A 120VAL A 349TYR A 355LEU A 359ILE A 523ALA A 527LEU A 531 | NoneSCL A 700 (-3.9A)SCL A 700 ( 4.6A)SCL A 700 (-4.3A)NoneSCL A 700 (-3.4A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.40A | 1eqgA-1ebvA:63.6 | 1eqgA-1ebvA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1EQG_B_IBPB1701_1 (PROSTAGLANDIN H2SYNTHASE-1) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 10 / 11 | VAL A 116ARG A 120VAL A 349SER A 353TYR A 355LEU A 359TYR A 385ILE A 523ALA A 527LEU A 531 | NoneSCL A 700 (-3.9A)SCL A 700 ( 4.6A)NoneSCL A 700 (-4.3A)NoneNoneSCL A 700 (-3.4A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.36A | 1eqgB-1ebvA:63.6 | 1eqgB-1ebvA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1EQH_A_FLPA701_1 (PROSTAGLANDIN H2SYNTHASE-1) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 11 / 12 | VAL A 116ARG A 120VAL A 349TYR A 355LEU A 359TYR A 385TRP A 387ILE A 523GLY A 526ALA A 527LEU A 531 | NoneSCL A 700 (-3.9A)SCL A 700 ( 4.6A)SCL A 700 (-4.3A)NoneNoneNoneSCL A 700 (-3.4A)SCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.34A | 1eqhA-1ebvA:63.7 | 1eqhA-1ebvA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1EQH_B_FLPB1701_1 (PROSTAGLANDIN H2SYNTHASE-1) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 11 / 12 | VAL A 116ARG A 120VAL A 349TYR A 355LEU A 359TYR A 385TRP A 387ILE A 523GLY A 526ALA A 527LEU A 531 | NoneSCL A 700 (-3.9A)SCL A 700 ( 4.6A)SCL A 700 (-4.3A)NoneNoneNoneSCL A 700 (-3.4A)SCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.35A | 1eqhB-1ebvA:63.7 | 1eqhB-1ebvA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FE2_A_LAXA700_1 (PROSTAGLANDINENDOPEROXIDE HSYNTHASE-1) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 10 / 10 | VAL A 116ARG A 120PHE A 205VAL A 228VAL A 344TYR A 348VAL A 349ASN A 375ILE A 523LEU A 531 | NoneSCL A 700 (-3.9A)OAS A 530 ( 4.7A)NoneNoneNoneSCL A 700 ( 4.6A)NoneSCL A 700 (-3.4A)OAS A 530 (-4.1A) | 0.30A | 1fe2A-1ebvA:61.4 | 1fe2A-1ebvA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FE2_A_LAXA700_1 (PROSTAGLANDINENDOPEROXIDE HSYNTHASE-1) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 5 / 10 | VAL A 116ARG A 120PHE A 209ILE A 523LEU A 531 | NoneSCL A 700 (-3.9A)NoneSCL A 700 (-3.4A)OAS A 530 (-4.1A) | 1.19A | 1fe2A-1ebvA:61.4 | 1fe2A-1ebvA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FE2_A_LAXA700_2 (PROSTAGLANDINENDOPEROXIDE HSYNTHASE-1) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 11 / 12 | PHE A 209LEU A 352TYR A 355PHE A 381TYR A 385TRP A 387PHE A 518GLY A 526ALA A 527GLY A 533LEU A 534 | NoneSCL A 700 ( 4.8A)SCL A 700 (-4.3A)OAS A 530 ( 4.7A)NoneNoneNoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 ( 4.0A)OAS A 530 ( 3.3A) | 0.34A | 1fe2A-1ebvA:61.4 | 1fe2A-1ebvA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FE2_A_LAXA700_2 (PROSTAGLANDINENDOPEROXIDE HSYNTHASE-1) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 7 / 12 | PHE A 210LEU A 352TYR A 355PHE A 381PHE A 518GLY A 526ALA A 527 | HEM A 601 (-4.7A)SCL A 700 ( 4.8A)SCL A 700 (-4.3A)OAS A 530 ( 4.7A)NoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A) | 1.46A | 1fe2A-1ebvA:61.4 | 1fe2A-1ebvA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1IGX_A_EPAA700_1 (PROSTAGLANDINENDOPEROXIDE HSYNTHASE-1) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 11 / 12 | PHE A 205PHE A 209LEU A 352TYR A 355PHE A 381TYR A 385TRP A 387GLY A 526ALA A 527GLY A 533LEU A 534 | OAS A 530 ( 4.7A)NoneSCL A 700 ( 4.8A)SCL A 700 (-4.3A)OAS A 530 ( 4.7A)NoneNoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 ( 4.0A)OAS A 530 ( 3.3A) | 0.39A | 1igxA-1ebvA:61.2 | 1igxA-1ebvA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1IGX_A_EPAA700_1 (PROSTAGLANDINENDOPEROXIDE HSYNTHASE-1) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 6 / 12 | PHE A 210LEU A 352TYR A 355PHE A 381GLY A 526ALA A 527 | HEM A 601 (-4.7A)SCL A 700 ( 4.8A)SCL A 700 (-4.3A)OAS A 530 ( 4.7A)SCL A 700 ( 4.0A)SCL A 700 (-2.9A) | 1.48A | 1igxA-1ebvA:61.2 | 1igxA-1ebvA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1IGX_A_EPAA700_2 (PROSTAGLANDINENDOPEROXIDE HSYNTHASE-1) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 8 / 8 | VAL A 116ARG A 120VAL A 344TYR A 348VAL A 349SER A 353ILE A 523LEU A 531 | NoneSCL A 700 (-3.9A)NoneNoneSCL A 700 ( 4.6A)NoneSCL A 700 (-3.4A)OAS A 530 (-4.1A) | 0.45A | 1igxA-1ebvA:61.2 | 1igxA-1ebvA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1PTH_A_SALA710_1 (PROSTAGLANDIN H2SYNTHASE-1) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 7 / 7 | VAL A 116ARG A 120VAL A 349LEU A 352TYR A 355ALA A 527LEU A 531 | NoneSCL A 700 (-3.9A)SCL A 700 ( 4.6A)SCL A 700 ( 4.8A)SCL A 700 (-4.3A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.36A | 1pthA-1ebvA:63.0 | 1pthA-1ebvA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1PTH_B_SALB711_1 (PROSTAGLANDIN H2SYNTHASE-1) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 7 / 7 | VAL A 116ARG A 120VAL A 349LEU A 352TYR A 355ALA A 527LEU A 531 | NoneSCL A 700 (-3.9A)SCL A 700 ( 4.6A)SCL A 700 ( 4.8A)SCL A 700 (-4.3A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.35A | 1pthB-1ebvA:63.0 | 1pthB-1ebvA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1PXX_A_DIFA701_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 8 / 10 | VAL A 349LEU A 352LEU A 384TYR A 385TRP A 387GLY A 526ALA A 527LEU A 531 | SCL A 700 ( 4.6A)SCL A 700 ( 4.8A)NoneNoneNoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.47A | 1pxxA-1ebvA:31.2 | 1pxxA-1ebvA:63.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1PXX_C_DIFC2701_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 10 / 12 | VAL A 349LEU A 352SER A 353TYR A 355LEU A 384TYR A 385TRP A 387GLY A 526ALA A 527LEU A 531 | SCL A 700 ( 4.6A)SCL A 700 ( 4.8A)NoneSCL A 700 (-4.3A)NoneNoneNoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.43A | 1pxxC-1ebvA:30.8 | 1pxxC-1ebvA:63.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE) |
5jd5 | MGS-MILE3 (unculturedbacterium) | 5 / 12 | GLY A 97GLY A 98GLY A 99PHE A 228HIS A 295 | OAS A 169 ( 4.3A)OAS A 169 ( 4.0A)OAS A 169 ( 3.0A)NoneOAS A 169 ( 4.1A) | 0.93A | 1qtiA-5jd5A:3.6 | 1qtiA-5jd5A:21.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ACE_A_ACHA998_0 (ACETYLCHOLINESTERASE) |
5jd5 | MGS-MILE3 (unculturedbacterium) | 5 / 9 | GLY A 98GLY A 99ALA A 170PHE A 228HIS A 295 | OAS A 169 ( 4.0A)OAS A 169 ( 3.0A)OAS A 169 ( 3.6A)NoneOAS A 169 ( 4.1A) | 0.82A | 2aceA-5jd5A:3.5 | 2aceA-5jd5A:21.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AYL_A_FLPA1701_1 (PROSTAGLANDIN G/HSYNTHASE 1) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 11 / 12 | ARG A 120VAL A 349LEU A 352TYR A 355LEU A 359TYR A 385TRP A 387PHE A 518GLY A 526ALA A 527LEU A 531 | SCL A 700 (-3.9A)SCL A 700 ( 4.6A)SCL A 700 ( 4.8A)SCL A 700 (-4.3A)NoneNoneNoneNoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.40A | 2aylA-1ebvA:63.4 | 2aylA-1ebvA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AYL_B_FLPB2701_1 (PROSTAGLANDIN G/HSYNTHASE 1) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 11 / 12 | ARG A 120VAL A 349LEU A 352TYR A 355LEU A 359TYR A 385TRP A 387ILE A 523GLY A 526ALA A 527LEU A 531 | SCL A 700 (-3.9A)SCL A 700 ( 4.6A)SCL A 700 ( 4.8A)SCL A 700 (-4.3A)NoneNoneNoneSCL A 700 (-3.4A)SCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.35A | 2aylB-1ebvA:63.1 | 2aylB-1ebvA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2HA4_B_ACTB601_0 (ACETYLCHOLINESTERASE) |
5jd5 | MGS-MILE3 (unculturedbacterium) | 5 / 7 | GLY A 98GLY A 99ALA A 170PHE A 228HIS A 295 | OAS A 169 ( 4.0A)OAS A 169 ( 3.0A)OAS A 169 ( 3.6A)NoneOAS A 169 ( 4.1A) | 0.87A | 2ha4B-5jd5A:16.1 | 2ha4B-5jd5A:22.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Q9R_A_BEZA203_0 (PROTEIN OF UNKNOWNFUNCTION) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 4 / 5 | LEU A 534GLY A 227ILE A 337ILE A 341 | OAS A 530 ( 3.3A)NoneNoneNone | 0.81A | 2q9rA-1ebvA:0.0 | 2q9rA-1ebvA:16.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2W98_A_P1ZA1352_1 (PROSTAGLANDINREDUCTASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 4 / 7 | TYR A 348LEU A 534LYS A 531TYR A 385 | NoneOAS A 530 ( 3.3A)OAS A 530 (-3.0A)None | 1.30A | 2w98A-1ebvA:undetectable2w98B-1ebvA:undetectable | 2w98A-1ebvA:21.902w98B-1ebvA:21.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2WQ5_A_MIYA1120_1 (PHOSPHOLIPASE A2,ACIDIC) |
5jd5 | MGS-MILE3 (unculturedbacterium) | 4 / 7 | LEU A 203TRP A 100ALA A 170GLY A 199 | NoneNoneOAS A 169 ( 3.6A)OAS A 169 ( 3.4A) | 0.92A | 2wq5A-5jd5A:undetectable | 2wq5A-5jd5A:16.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3AXZ_A_ADNA401_1 (TRNA(GUANINE-N(1)-)-METHYLTRANSFERASE) |
5jd5 | MGS-MILE3 (unculturedbacterium) | 5 / 12 | LEU A 196GLY A 199ILE A 165GLY A 171GLY A 172 | NoneOAS A 169 ( 3.4A)NoneOAS A 169 ( 3.8A)OAS A 169 ( 3.1A) | 1.09A | 3axzA-5jd5A:undetectable | 3axzA-5jd5A:22.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HS6_A_EPAA1_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 9 / 12 | VAL A 116VAL A 349SER A 353TYR A 355TYR A 385TRP A 387GLY A 526ALA A 527LEU A 534 | NoneSCL A 700 ( 4.6A)NoneSCL A 700 (-4.3A)NoneNoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 ( 3.3A) | 0.50A | 3hs6A-1ebvA:57.8 | 3hs6A-1ebvA:63.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HS6_B_EPAB1_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 11 / 12 | PHE A 209GLY A 227TYR A 355ASN A 375ILE A 377PHE A 381TYR A 385GLY A 526ALA A 527GLY A 533LEU A 534 | NoneNoneSCL A 700 (-4.3A)NoneNoneOAS A 530 ( 4.7A)NoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 ( 4.0A)OAS A 530 ( 3.3A) | 0.38A | 3hs6B-1ebvA:30.3 | 3hs6B-1ebvA:63.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HS6_B_EPAB1_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 6 / 12 | PHE A 210TYR A 355ILE A 377PHE A 381GLY A 526ALA A 527 | HEM A 601 (-4.7A)SCL A 700 (-4.3A)NoneOAS A 530 ( 4.7A)SCL A 700 ( 4.0A)SCL A 700 (-2.9A) | 1.34A | 3hs6B-1ebvA:30.3 | 3hs6B-1ebvA:63.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HS6_B_EPAB1_2 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 6 / 7 | PHE A 205VAL A 344VAL A 349LEU A 352SER A 353TRP A 387 | OAS A 530 ( 4.7A)NoneSCL A 700 ( 4.6A)SCL A 700 ( 4.8A)NoneNone | 0.31A | 3hs6B-1ebvA:30.3 | 3hs6B-1ebvA:63.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3KK6_A_CELA701_2 (PROSTAGLANDIN G/HSYNTHASE 1) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 6 / 6 | HIS A 90VAL A 116SER A 353LEU A 384ILE A 517LEU A 531 | NoneNoneNoneNoneNoneOAS A 530 (-4.1A) | 0.45A | 3kk6A-1ebvA:59.7 | 3kk6A-1ebvA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3KK6_B_CELB1701_2 (PROSTAGLANDIN G/HSYNTHASE 1) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 6 / 6 | VAL A 116SER A 353LEU A 384ILE A 517ALA A 527LEU A 531 | NoneNoneNoneNoneSCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.48A | 3kk6B-1ebvA:59.6 | 3kk6B-1ebvA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3LN1_A_CELA682_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 9 / 12 | HIS A 90GLN A 192VAL A 349TYR A 355LEU A 359TRP A 387GLY A 526ALA A 527LEU A 531 | NoneNoneSCL A 700 ( 4.6A)SCL A 700 (-4.3A)NoneNoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.31A | 3ln1A-1ebvA:58.3 | 3ln1A-1ebvA:64.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3LN1_B_CELB682_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 9 / 12 | HIS A 90GLN A 192VAL A 349TYR A 355LEU A 359TRP A 387GLY A 526ALA A 527LEU A 531 | NoneNoneSCL A 700 ( 4.6A)SCL A 700 (-4.3A)NoneNoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.29A | 3ln1B-1ebvA:58.3 | 3ln1B-1ebvA:64.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3LN1_C_CELC682_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 9 / 12 | HIS A 90VAL A 349TYR A 355LEU A 359TYR A 385TRP A 387GLY A 526ALA A 527LEU A 531 | NoneSCL A 700 ( 4.6A)SCL A 700 (-4.3A)NoneNoneNoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.32A | 3ln1C-1ebvA:58.3 | 3ln1C-1ebvA:64.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3LN1_D_CELD682_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 10 / 12 | HIS A 90GLN A 192VAL A 349SER A 353TYR A 355LEU A 359TRP A 387GLY A 526ALA A 527LEU A 531 | NoneNoneSCL A 700 ( 4.6A)NoneSCL A 700 (-4.3A)NoneNoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.30A | 3ln1D-1ebvA:30.7 | 3ln1D-1ebvA:64.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3N8W_A_FLPA701_1 (PROSTAGLANDIN G/HSYNTHASE 1) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 11 / 12 | VAL A 116ARG A 120VAL A 349LEU A 352TYR A 355LEU A 359TYR A 385TRP A 387GLY A 526ALA A 527LEU A 531 | NoneSCL A 700 (-3.9A)SCL A 700 ( 4.6A)SCL A 700 ( 4.8A)SCL A 700 (-4.3A)NoneNoneNoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.37A | 3n8wA-1ebvA:62.2 | 3n8wA-1ebvA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3N8X_A_NIMA701_1 (PROSTAGLANDIN G/HSYNTHASE 1) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 11 / 12 | HIS A 90ARG A 120LEU A 352TYR A 355TYR A 385TRP A 387PHE A 518ILE A 523GLY A 526ALA A 527LEU A 531 | NoneSCL A 700 (-3.9A)SCL A 700 ( 4.8A)SCL A 700 (-4.3A)NoneNoneNoneSCL A 700 (-3.4A)SCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.45A | 3n8xA-1ebvA:61.6 | 3n8xA-1ebvA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3N8X_B_NIMB1701_1 (PROSTAGLANDIN G/HSYNTHASE 1) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 11 / 12 | HIS A 90ARG A 120LEU A 352TYR A 355LEU A 359TRP A 387PHE A 518ILE A 523GLY A 526ALA A 527LEU A 531 | NoneSCL A 700 (-3.9A)SCL A 700 ( 4.8A)SCL A 700 (-4.3A)NoneNoneNoneSCL A 700 (-3.4A)SCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.40A | 3n8xB-1ebvA:61.5 | 3n8xB-1ebvA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3N8Y_A_DIFA701_1 (PROSTAGLANDIN G/HSYNTHASE 1) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 10 / 11 | VAL A 349LEU A 352SER A 353TYR A 355TYR A 385TRP A 387ILE A 523GLY A 526ALA A 527LEU A 531 | SCL A 700 ( 4.6A)SCL A 700 ( 4.8A)NoneSCL A 700 (-4.3A)NoneNoneSCL A 700 (-3.4A)SCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.57A | 3n8yA-1ebvA:61.9 | 3n8yA-1ebvA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3N8Y_B_DIFB585_1 (PROSTAGLANDIN G/HSYNTHASE 1) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 12 / 12 | VAL A 344VAL A 349LEU A 352SER A 353TYR A 355TYR A 385TRP A 387ILE A 523GLY A 526ALA A 527LEU A 531LEU A 534 | NoneSCL A 700 ( 4.6A)SCL A 700 ( 4.8A)NoneSCL A 700 (-4.3A)NoneNoneSCL A 700 (-3.4A)SCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A)OAS A 530 ( 3.3A) | 0.46A | 3n8yB-1ebvA:61.4 | 3n8yB-1ebvA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3N8Z_A_FLPA701_1 (PROSTAGLANDIN G/HSYNTHASE 1) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 11 / 12 | VAL A 116ARG A 120VAL A 349LEU A 352TYR A 355LEU A 359TYR A 385TRP A 387GLY A 526ALA A 527LEU A 531 | NoneSCL A 700 (-3.9A)SCL A 700 ( 4.6A)SCL A 700 ( 4.8A)SCL A 700 (-4.3A)NoneNoneNoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.35A | 3n8zA-1ebvA:61.5 | 3n8zA-1ebvA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3N8Z_B_FLPB1701_1 (PROSTAGLANDIN G/HSYNTHASE 1) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 11 / 12 | ARG A 120VAL A 349LEU A 352TYR A 355LEU A 384TYR A 385TRP A 387ILE A 523GLY A 526ALA A 527LEU A 531 | SCL A 700 (-3.9A)SCL A 700 ( 4.6A)SCL A 700 ( 4.8A)SCL A 700 (-4.3A)NoneNoneNoneSCL A 700 (-3.4A)SCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.37A | 3n8zB-1ebvA:62.0 | 3n8zB-1ebvA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3NT1_A_NPSA5_1 (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 10 / 12 | ARG A 120VAL A 349LEU A 352TYR A 355LEU A 359TYR A 385TRP A 387GLY A 526ALA A 527LEU A 531 | SCL A 700 (-3.9A)SCL A 700 ( 4.6A)SCL A 700 ( 4.8A)SCL A 700 (-4.3A)NoneNoneNoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.58A | 3nt1A-1ebvA:30.6 | 3nt1A-1ebvA:64.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3NT1_B_NPSB4_1 (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 10 / 12 | ARG A 120VAL A 349LEU A 352TYR A 355LEU A 359TYR A 385TRP A 387GLY A 526ALA A 527LEU A 531 | SCL A 700 (-3.9A)SCL A 700 ( 4.6A)SCL A 700 ( 4.8A)SCL A 700 (-4.3A)NoneNoneNoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.58A | 3nt1B-1ebvA:58.6 | 3nt1B-1ebvA:64.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3O9M_A_BEZA999_0 (CHOLINESTERASE) |
5jd5 | MGS-MILE3 (unculturedbacterium) | 4 / 7 | GLY A 98GLY A 99LEU A 225HIS A 295 | OAS A 169 ( 4.0A)OAS A 169 ( 3.0A)NoneOAS A 169 ( 4.1A) | 0.54A | 3o9mA-5jd5A:3.1 | 3o9mA-5jd5A:19.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3O9M_B_BEZB999_0 (CHOLINESTERASE) |
5jd5 | MGS-MILE3 (unculturedbacterium) | 4 / 6 | GLY A 98GLY A 99LEU A 225HIS A 295 | OAS A 169 ( 4.0A)OAS A 169 ( 3.0A)NoneOAS A 169 ( 4.1A) | 0.55A | 3o9mB-5jd5A:7.8 | 3o9mB-5jd5A:19.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3PGH_A_FLPA701_1 (CYCLOOXYGENASE-2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 10 / 12 | VAL A 116VAL A 349LEU A 352TYR A 355LEU A 359TYR A 385TRP A 387GLY A 526ALA A 527LEU A 531 | NoneSCL A 700 ( 4.6A)SCL A 700 ( 4.8A)SCL A 700 (-4.3A)NoneNoneNoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.42A | 3pghA-1ebvA:23.5 | 3pghA-1ebvA:64.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3PGH_C_FLPC701_1 (CYCLOOXYGENASE-2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 10 / 12 | VAL A 116VAL A 349LEU A 352TYR A 355LEU A 359TYR A 385TRP A 387GLY A 526ALA A 527LEU A 531 | NoneSCL A 700 ( 4.6A)SCL A 700 ( 4.8A)SCL A 700 (-4.3A)NoneNoneNoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.42A | 3pghC-1ebvA:25.5 | 3pghC-1ebvA:64.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3PGH_D_FLPD701_1 (CYCLOOXYGENASE-2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 10 / 12 | ARG A 120VAL A 349LEU A 352TYR A 355LEU A 359TYR A 385TRP A 387GLY A 526ALA A 527LEU A 531 | SCL A 700 (-3.9A)SCL A 700 ( 4.6A)SCL A 700 ( 4.8A)SCL A 700 (-4.3A)NoneNoneNoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.45A | 3pghD-1ebvA:23.3 | 3pghD-1ebvA:64.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3RR3_A_FLRA700_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 10 / 12 | VAL A 116ARG A 120VAL A 349TYR A 355LEU A 359TYR A 385TRP A 387GLY A 526ALA A 527LEU A 531 | NoneSCL A 700 (-3.9A)SCL A 700 ( 4.6A)SCL A 700 (-4.3A)NoneNoneNoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.40A | 3rr3A-1ebvA:31.6 | 3rr3A-1ebvA:64.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3RR3_B_FLRB700_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 10 / 12 | VAL A 116ARG A 120VAL A 349TYR A 355LEU A 359TYR A 385TRP A 387GLY A 526ALA A 527LEU A 531 | NoneSCL A 700 (-3.9A)SCL A 700 ( 4.6A)SCL A 700 (-4.3A)NoneNoneNoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.40A | 3rr3B-1ebvA:31.2 | 3rr3B-1ebvA:64.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4COX_A_IMNA701_1 (CYCLOOXYGENASE-2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 9 / 12 | ARG A 120VAL A 349SER A 353TYR A 355TYR A 385TRP A 387GLY A 526ALA A 527LEU A 531 | SCL A 700 (-3.9A)SCL A 700 ( 4.6A)NoneSCL A 700 (-4.3A)NoneNoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.44A | 4coxA-1ebvA:22.3 | 4coxA-1ebvA:64.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4COX_A_IMNA701_1 (CYCLOOXYGENASE-2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 7 / 12 | ARG A 120VAL A 349TYR A 355LEU A 384GLY A 526ALA A 527LEU A 531 | SCL A 700 (-3.9A)SCL A 700 ( 4.6A)SCL A 700 (-4.3A)NoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.69A | 4coxA-1ebvA:22.3 | 4coxA-1ebvA:64.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4COX_B_IMNB701_1 (CYCLOOXYGENASE-2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 8 / 12 | ARG A 120VAL A 349SER A 353TYR A 355LEU A 384GLY A 526ALA A 527LEU A 531 | SCL A 700 (-3.9A)SCL A 700 ( 4.6A)NoneSCL A 700 (-4.3A)NoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.70A | 4coxB-1ebvA:57.9 | 4coxB-1ebvA:64.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4COX_B_IMNB701_1 (CYCLOOXYGENASE-2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 9 / 12 | ARG A 120VAL A 349SER A 353TYR A 355TYR A 385TRP A 387GLY A 526ALA A 527LEU A 531 | SCL A 700 (-3.9A)SCL A 700 ( 4.6A)NoneSCL A 700 (-4.3A)NoneNoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.43A | 4coxB-1ebvA:57.9 | 4coxB-1ebvA:64.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4COX_C_IMNC701_1 (CYCLOOXYGENASE-2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 10 / 12 | ARG A 120VAL A 349LEU A 352SER A 353TYR A 355TYR A 385TRP A 387GLY A 526ALA A 527LEU A 531 | SCL A 700 (-3.9A)SCL A 700 ( 4.6A)SCL A 700 ( 4.8A)NoneSCL A 700 (-4.3A)NoneNoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.44A | 4coxC-1ebvA:14.9 | 4coxC-1ebvA:64.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4COX_D_IMND701_1 (CYCLOOXYGENASE-2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 8 / 12 | ARG A 120VAL A 349SER A 353TYR A 355LEU A 384GLY A 526ALA A 527LEU A 531 | SCL A 700 (-3.9A)SCL A 700 ( 4.6A)NoneSCL A 700 (-4.3A)NoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.70A | 4coxD-1ebvA:30.8 | 4coxD-1ebvA:64.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4COX_D_IMND701_1 (CYCLOOXYGENASE-2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 9 / 12 | ARG A 120VAL A 349SER A 353TYR A 355TYR A 385TRP A 387GLY A 526ALA A 527LEU A 531 | SCL A 700 (-3.9A)SCL A 700 ( 4.6A)NoneSCL A 700 (-4.3A)NoneNoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.43A | 4coxD-1ebvA:30.8 | 4coxD-1ebvA:64.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4E1G_A_LNLA701_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 11 / 12 | PHE A 205PHE A 209TYR A 355ASN A 375ILE A 377PHE A 381TYR A 385GLY A 526ALA A 527GLY A 533LEU A 534 | OAS A 530 ( 4.7A)NoneSCL A 700 (-4.3A)NoneNoneOAS A 530 ( 4.7A)NoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 ( 4.0A)OAS A 530 ( 3.3A) | 0.33A | 4e1gA-1ebvA:58.5 | 4e1gA-1ebvA:62.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4E1G_A_LNLA701_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 6 / 12 | PHE A 210TYR A 355ILE A 377PHE A 381GLY A 526ALA A 527 | HEM A 601 (-4.7A)SCL A 700 (-4.3A)NoneOAS A 530 ( 4.7A)SCL A 700 ( 4.0A)SCL A 700 (-2.9A) | 1.29A | 4e1gA-1ebvA:58.5 | 4e1gA-1ebvA:62.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4E1G_B_LNLB701_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 11 / 12 | ARG A 120PHE A 205PHE A 209TYR A 355ILE A 377PHE A 381TYR A 385GLY A 526ALA A 527GLY A 533LEU A 534 | SCL A 700 (-3.9A)OAS A 530 ( 4.7A)NoneSCL A 700 (-4.3A)NoneOAS A 530 ( 4.7A)NoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 ( 4.0A)OAS A 530 ( 3.3A) | 0.41A | 4e1gB-1ebvA:58.5 | 4e1gB-1ebvA:62.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4E1G_B_LNLB701_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 6 / 12 | PHE A 210TYR A 355ILE A 377PHE A 381GLY A 526ALA A 527 | HEM A 601 (-4.7A)SCL A 700 (-4.3A)NoneOAS A 530 ( 4.7A)SCL A 700 ( 4.0A)SCL A 700 (-2.9A) | 1.32A | 4e1gB-1ebvA:58.5 | 4e1gB-1ebvA:62.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4EY6_A_GNTA604_1 (ACETYLCHOLINESTERASE) |
5jd5 | MGS-MILE3 (unculturedbacterium) | 5 / 12 | GLY A 97GLY A 98GLY A 99PHE A 228HIS A 295 | OAS A 169 ( 4.3A)OAS A 169 ( 4.0A)OAS A 169 ( 3.0A)NoneOAS A 169 ( 4.1A) | 0.92A | 4ey6A-5jd5A:7.7 | 4ey6A-5jd5A:23.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4EY6_B_GNTB605_1 (ACETYLCHOLINESTERASE) |
5jd5 | MGS-MILE3 (unculturedbacterium) | 5 / 12 | GLY A 97GLY A 98GLY A 99PHE A 228HIS A 295 | OAS A 169 ( 4.3A)OAS A 169 ( 4.0A)OAS A 169 ( 3.0A)NoneOAS A 169 ( 4.1A) | 0.91A | 4ey6B-5jd5A:15.7 | 4ey6B-5jd5A:23.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4M11_B_MXMB606_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 10 / 12 | MET A 113VAL A 116ARG A 120ILE A 345VAL A 349LEU A 352LEU A 359TRP A 387ALA A 527LEU A 534 | NoneNoneSCL A 700 (-3.9A)NoneSCL A 700 ( 4.6A)SCL A 700 ( 4.8A)NoneNoneSCL A 700 (-2.9A)OAS A 530 ( 3.3A) | 0.74A | 4m11B-1ebvA:57.9 | 4m11B-1ebvA:64.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4M11_B_MXMB606_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 7 / 12 | MET A 113VAL A 116ARG A 120LEU A 352ALA A 527LEU A 531LEU A 534 | NoneNoneSCL A 700 (-3.9A)SCL A 700 ( 4.8A)SCL A 700 (-2.9A)OAS A 530 (-4.1A)OAS A 530 ( 3.3A) | 1.24A | 4m11B-1ebvA:57.9 | 4m11B-1ebvA:64.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4M11_C_MXMC606_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 6 / 12 | ILE A 345LEU A 352LEU A 359TRP A 387ALA A 527LEU A 534 | NoneSCL A 700 ( 4.8A)NoneNoneSCL A 700 (-2.9A)OAS A 530 ( 3.3A) | 0.64A | 4m11C-1ebvA:33.5 | 4m11C-1ebvA:64.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4M11_C_MXMC606_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 7 / 12 | MET A 113ILE A 345VAL A 349LEU A 359TRP A 387ALA A 527LEU A 534 | NoneNoneSCL A 700 ( 4.6A)NoneNoneSCL A 700 (-2.9A)OAS A 530 ( 3.3A) | 0.48A | 4m11C-1ebvA:33.5 | 4m11C-1ebvA:64.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4M11_C_MXMC606_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 7 / 12 | MET A 113VAL A 116ILE A 345VAL A 349LEU A 359TRP A 387LEU A 534 | NoneNoneNoneSCL A 700 ( 4.6A)NoneNoneOAS A 530 ( 3.3A) | 0.62A | 4m11C-1ebvA:33.5 | 4m11C-1ebvA:64.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4O1Z_A_MXMA807_1 (PROSTAGLANDIN G/HSYNTHASE 1) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 10 / 12 | MET A 113ILE A 345VAL A 349LEU A 352TRP A 387ILE A 523GLY A 526ALA A 527LEU A 534LEU A 535 | NoneNoneSCL A 700 ( 4.6A)SCL A 700 ( 4.8A)NoneSCL A 700 (-3.4A)SCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 ( 3.3A)None | 0.56A | 4o1zA-1ebvA:62.2 | 4o1zA-1ebvA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4O1Z_A_MXMA807_1 (PROSTAGLANDIN G/HSYNTHASE 1) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 7 / 12 | MET A 113ILE A 523GLY A 526ALA A 527LEU A 531LEU A 534LEU A 535 | NoneSCL A 700 (-3.4A)SCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A)OAS A 530 ( 3.3A)None | 1.07A | 4o1zA-1ebvA:62.2 | 4o1zA-1ebvA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4O1Z_B_MXMB807_1 (PROSTAGLANDIN G/HSYNTHASE 1) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 6 / 12 | MET A 113VAL A 116LEU A 117ARG A 120ALA A 527LEU A 531 | NoneNoneNoneSCL A 700 (-3.9A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.92A | 4o1zB-1ebvA:62.4 | 4o1zB-1ebvA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4O33_A_TZNA501_1 (PHOSPHOGLYCERATEKINASE 1) |
5jd5 | MGS-MILE3 (unculturedbacterium) | 5 / 12 | ALA A 200GLY A 199PHE A 198LEU A 267GLY A 171 | NoneOAS A 169 ( 3.4A)OAS A 169 ( 4.8A)NoneOAS A 169 ( 3.8A) | 0.91A | 4o33A-5jd5A:undetectable | 4o33A-5jd5A:22.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OTY_A_LURA705_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 8 / 12 | VAL A 349LEU A 352SER A 353TYR A 355LEU A 384GLY A 526ALA A 527LEU A 531 | SCL A 700 ( 4.6A)SCL A 700 ( 4.8A)NoneSCL A 700 (-4.3A)NoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.65A | 4otyA-1ebvA:30.7 | 4otyA-1ebvA:64.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OTY_A_LURA705_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 9 / 12 | VAL A 349LEU A 352SER A 353TYR A 355TYR A 385TRP A 387GLY A 526ALA A 527LEU A 531 | SCL A 700 ( 4.6A)SCL A 700 ( 4.8A)NoneSCL A 700 (-4.3A)NoneNoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.39A | 4otyA-1ebvA:30.7 | 4otyA-1ebvA:64.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OTY_B_LURB705_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 8 / 12 | VAL A 349LEU A 352SER A 353TYR A 355LEU A 384GLY A 526ALA A 527LEU A 531 | SCL A 700 ( 4.6A)SCL A 700 ( 4.8A)NoneSCL A 700 (-4.3A)NoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.62A | 4otyB-1ebvA:30.6 | 4otyB-1ebvA:64.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OTY_B_LURB705_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 9 / 12 | VAL A 349LEU A 352SER A 353TYR A 355TYR A 385TRP A 387GLY A 526ALA A 527LEU A 531 | SCL A 700 ( 4.6A)SCL A 700 ( 4.8A)NoneSCL A 700 (-4.3A)NoneNoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.35A | 4otyB-1ebvA:30.6 | 4otyB-1ebvA:64.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4P6X_I_HCYI900_1 (GLUCOCORTICOIDRECEPTOR) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 5 / 12 | LEU A 534ASN A 537GLY A 536GLN A 208ILE A 337 | OAS A 530 ( 3.3A)NoneNoneNoneNone | 1.15A | 4p6xI-1ebvA:undetectable | 4p6xI-1ebvA:21.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4PH9_A_IBPA601_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 9 / 10 | VAL A 116ARG A 120VAL A 349TYR A 355LEU A 359TRP A 387GLY A 526ALA A 527LEU A 531 | NoneSCL A 700 (-3.9A)SCL A 700 ( 4.6A)SCL A 700 (-4.3A)NoneNoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.39A | 4ph9A-1ebvA:58.8 | 4ph9A-1ebvA:64.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4PH9_B_IBPB601_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 9 / 10 | VAL A 116ARG A 120VAL A 349TYR A 355LEU A 359TRP A 387GLY A 526ALA A 527LEU A 531 | NoneSCL A 700 (-3.9A)SCL A 700 ( 4.6A)SCL A 700 (-4.3A)NoneNoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.34A | 4ph9B-1ebvA:58.8 | 4ph9B-1ebvA:64.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RRW_A_LURA705_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 10 / 12 | VAL A 349LEU A 352SER A 353TYR A 355TYR A 385TRP A 387MET A 522GLY A 526ALA A 527LEU A 531 | SCL A 700 ( 4.6A)SCL A 700 ( 4.8A)NoneSCL A 700 (-4.3A)NoneNoneNoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.56A | 4rrwA-1ebvA:58.1 | 4rrwA-1ebvA:64.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RRW_B_LURB705_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 10 / 12 | VAL A 349LEU A 352SER A 353TYR A 355TYR A 385TRP A 387MET A 522GLY A 526ALA A 527LEU A 531 | SCL A 700 ( 4.6A)SCL A 700 ( 4.8A)NoneSCL A 700 (-4.3A)NoneNoneNoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.55A | 4rrwB-1ebvA:32.7 | 4rrwB-1ebvA:64.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RRW_C_LURC705_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 9 / 12 | VAL A 349LEU A 352SER A 353TYR A 355TYR A 385TRP A 387GLY A 526ALA A 527LEU A 531 | SCL A 700 ( 4.6A)SCL A 700 ( 4.8A)NoneSCL A 700 (-4.3A)NoneNoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.55A | 4rrwC-1ebvA:58.1 | 4rrwC-1ebvA:64.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RRW_C_LURC705_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 7 / 12 | VAL A 349SER A 353TYR A 355LEU A 384GLY A 526ALA A 527LEU A 531 | SCL A 700 ( 4.6A)NoneSCL A 700 (-4.3A)NoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.64A | 4rrwC-1ebvA:58.1 | 4rrwC-1ebvA:64.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RRW_D_LURD705_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 5 / 12 | TYR A 355LEU A 384GLY A 526ALA A 527LEU A 531 | SCL A 700 (-4.3A)NoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.79A | 4rrwD-1ebvA:58.1 | 4rrwD-1ebvA:64.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RRW_D_LURD705_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 9 / 12 | VAL A 349LEU A 352SER A 353TYR A 355TYR A 385TRP A 387GLY A 526ALA A 527LEU A 531 | SCL A 700 ( 4.6A)SCL A 700 ( 4.8A)NoneSCL A 700 (-4.3A)NoneNoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.36A | 4rrwD-1ebvA:58.1 | 4rrwD-1ebvA:64.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RRX_A_LURA706_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 10 / 12 | TYR A 348VAL A 349LEU A 352TYR A 355LEU A 384TYR A 385TRP A 387GLY A 526ALA A 527LEU A 531 | NoneSCL A 700 ( 4.6A)SCL A 700 ( 4.8A)SCL A 700 (-4.3A)NoneNoneNoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.67A | 4rrxA-1ebvA:57.7 | 4rrxA-1ebvA:64.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RRX_B_LURB706_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 10 / 12 | TYR A 348VAL A 349LEU A 352TYR A 355LEU A 384TYR A 385TRP A 387GLY A 526ALA A 527LEU A 531 | NoneSCL A 700 ( 4.6A)SCL A 700 ( 4.8A)SCL A 700 (-4.3A)NoneNoneNoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.67A | 4rrxB-1ebvA:32.4 | 4rrxB-1ebvA:64.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RRZ_A_LURA705_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 10 / 12 | VAL A 349LEU A 352SER A 353TYR A 355TYR A 385TRP A 387MET A 522GLY A 526ALA A 527LEU A 531 | SCL A 700 ( 4.6A)SCL A 700 ( 4.8A)NoneSCL A 700 (-4.3A)NoneNoneNoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.56A | 4rrzA-1ebvA:58.1 | 4rrzA-1ebvA:64.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RRZ_B_LURB705_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 10 / 12 | VAL A 349LEU A 352SER A 353TYR A 355TYR A 385TRP A 387MET A 522GLY A 526ALA A 527LEU A 531 | SCL A 700 ( 4.6A)SCL A 700 ( 4.8A)NoneSCL A 700 (-4.3A)NoneNoneNoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.55A | 4rrzB-1ebvA:32.7 | 4rrzB-1ebvA:64.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RRZ_C_LURC705_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 9 / 12 | VAL A 349LEU A 352SER A 353TYR A 355TYR A 385TRP A 387GLY A 526ALA A 527LEU A 531 | SCL A 700 ( 4.6A)SCL A 700 ( 4.8A)NoneSCL A 700 (-4.3A)NoneNoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.55A | 4rrzC-1ebvA:58.1 | 4rrzC-1ebvA:64.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RRZ_C_LURC705_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 7 / 12 | VAL A 349SER A 353TYR A 355LEU A 384GLY A 526ALA A 527LEU A 531 | SCL A 700 ( 4.6A)NoneSCL A 700 (-4.3A)NoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.64A | 4rrzC-1ebvA:58.1 | 4rrzC-1ebvA:64.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RRZ_D_LURD705_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 5 / 12 | TYR A 355LEU A 384GLY A 526ALA A 527LEU A 531 | SCL A 700 (-4.3A)NoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.79A | 4rrzD-1ebvA:58.1 | 4rrzD-1ebvA:64.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RRZ_D_LURD705_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 9 / 12 | VAL A 349LEU A 352SER A 353TYR A 355TYR A 385TRP A 387GLY A 526ALA A 527LEU A 531 | SCL A 700 ( 4.6A)SCL A 700 ( 4.8A)NoneSCL A 700 (-4.3A)NoneNoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.36A | 4rrzD-1ebvA:58.1 | 4rrzD-1ebvA:64.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RS0_A_IBPA706_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 9 / 9 | ARG A 120VAL A 349LEU A 352SER A 353TYR A 355LEU A 359GLY A 526ALA A 527LEU A 531 | SCL A 700 (-3.9A)SCL A 700 ( 4.6A)SCL A 700 ( 4.8A)NoneSCL A 700 (-4.3A)NoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.38A | 4rs0A-1ebvA:33.8 | 4rs0A-1ebvA:64.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4Y8W_A_STRA604_1 (CYTOCHROME P45021-HYDROXYLASE) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 5 / 12 | LEU A 230ILE A 337GLY A 338VAL A 344LEU A 534 | NoneNoneNoneNoneOAS A 530 ( 3.3A) | 1.10A | 4y8wA-1ebvA:0.0 | 4y8wA-1ebvA:22.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YVG_A_SAMA301_0 (TRNA(GUANINE-N(1)-)-METHYLTRANSFERASE) |
5jd5 | MGS-MILE3 (unculturedbacterium) | 5 / 12 | LEU A 196GLY A 199ILE A 165GLY A 171GLY A 172 | NoneOAS A 169 ( 3.4A)NoneOAS A 169 ( 3.8A)OAS A 169 ( 3.1A) | 1.08A | 4yvgA-5jd5A:undetectable | 4yvgA-5jd5A:22.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5IKQ_A_JMSA602_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 10 / 12 | ARG A 120VAL A 349LEU A 352TYR A 355LEU A 384TYR A 385TRP A 387GLY A 526ALA A 527LEU A 531 | SCL A 700 (-3.9A)SCL A 700 ( 4.6A)SCL A 700 ( 4.8A)SCL A 700 (-4.3A)NoneNoneNoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.46A | 5ikqA-1ebvA:33.9 | 5ikqA-1ebvA:63.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5IKQ_B_JMSB602_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 10 / 12 | ARG A 120VAL A 349LEU A 352TYR A 355LEU A 384TYR A 385TRP A 387GLY A 526ALA A 527LEU A 531 | SCL A 700 (-3.9A)SCL A 700 ( 4.6A)SCL A 700 ( 4.8A)SCL A 700 (-4.3A)NoneNoneNoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.48A | 5ikqB-1ebvA:33.8 | 5ikqB-1ebvA:63.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5IKR_A_ID8A601_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 10 / 12 | ARG A 120VAL A 349LEU A 352SER A 353TYR A 355TYR A 385TRP A 387GLY A 526ALA A 527LEU A 531 | SCL A 700 (-3.9A)SCL A 700 ( 4.6A)SCL A 700 ( 4.8A)NoneSCL A 700 (-4.3A)NoneNoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.49A | 5ikrA-1ebvA:58.6 | 5ikrA-1ebvA:63.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5IKR_B_ID8B602_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 10 / 12 | ARG A 120VAL A 349LEU A 352TYR A 355LEU A 359TYR A 385TRP A 387GLY A 526ALA A 527LEU A 531 | SCL A 700 (-3.9A)SCL A 700 ( 4.6A)SCL A 700 ( 4.8A)SCL A 700 (-4.3A)NoneNoneNoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.42A | 5ikrB-1ebvA:58.5 | 5ikrB-1ebvA:63.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5IKT_A_TLFA601_0 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 11 / 12 | VAL A 116ARG A 120VAL A 349SER A 353TYR A 355LEU A 384TRP A 387MET A 522GLY A 526ALA A 527LEU A 531 | NoneSCL A 700 (-3.9A)SCL A 700 ( 4.6A)NoneSCL A 700 (-4.3A)NoneNoneNoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.45A | 5iktA-1ebvA:35.0 | 5iktA-1ebvA:63.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5IKT_B_TLFB601_0 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 11 / 12 | VAL A 116ARG A 120VAL A 349LEU A 352SER A 353LEU A 384TRP A 387MET A 522GLY A 526ALA A 527LEU A 531 | NoneSCL A 700 (-3.9A)SCL A 700 ( 4.6A)SCL A 700 ( 4.8A)NoneNoneNoneNoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.44A | 5iktB-1ebvA:58.8 | 5iktB-1ebvA:63.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JVZ_A_FLPA601_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 10 / 12 | ARG A 120VAL A 349LEU A 352TYR A 355LEU A 359TYR A 385TRP A 387GLY A 526ALA A 527LEU A 531 | SCL A 700 (-3.9A)SCL A 700 ( 4.6A)SCL A 700 ( 4.8A)SCL A 700 (-4.3A)NoneNoneNoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.56A | 5jvzA-1ebvA:58.5 | 5jvzA-1ebvA:64.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JVZ_B_FLPB601_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 11 / 12 | ARG A 120VAL A 349LEU A 352SER A 353TYR A 355LEU A 359TYR A 385TRP A 387GLY A 526ALA A 527LEU A 531 | SCL A 700 (-3.9A)SCL A 700 ( 4.6A)SCL A 700 ( 4.8A)NoneSCL A 700 (-4.3A)NoneNoneNoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.58A | 5jvzB-1ebvA:58.3 | 5jvzB-1ebvA:64.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JW1_A_CELA602_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 9 / 12 | HIS A 90GLN A 192VAL A 349TYR A 355LEU A 359TRP A 387GLY A 526ALA A 527LEU A 531 | NoneNoneSCL A 700 ( 4.6A)SCL A 700 (-4.3A)NoneNoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.32A | 5jw1A-1ebvA:57.4 | 5jw1A-1ebvA:64.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JW1_B_CELB602_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 9 / 12 | HIS A 90GLN A 192LEU A 352TYR A 355LEU A 359TRP A 387GLY A 526ALA A 527LEU A 531 | NoneNoneSCL A 700 ( 4.8A)SCL A 700 (-4.3A)NoneNoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.36A | 5jw1B-1ebvA:57.4 | 5jw1B-1ebvA:64.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5KIR_A_RCXA601_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 9 / 12 | HIS A 90GLN A 192VAL A 349LEU A 352TYR A 355TRP A 387GLY A 526ALA A 527LEU A 531 | NoneNoneSCL A 700 ( 4.6A)SCL A 700 ( 4.8A)SCL A 700 (-4.3A)NoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.30A | 5kirA-1ebvA:58.4 | 5kirA-1ebvA:63.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5KIR_B_RCXB601_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
1ebv | PROSTAGLANDIN H2SYNTHASE (Ovisaries) | 9 / 12 | HIS A 90GLN A 192VAL A 349SER A 353TYR A 355TRP A 387GLY A 526ALA A 527LEU A 531 | NoneNoneSCL A 700 ( 4.6A)NoneSCL A 700 (-4.3A)NoneSCL A 700 ( 4.0A)SCL A 700 (-2.9A)OAS A 530 (-4.1A) | 0.34A | 5kirB-1ebvA:58.7 | 5kirB-1ebvA:63.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5KPC_B_SAMB401_0 (PAVINEN-METHYLTRANSFERASE) |
5jd5 | MGS-MILE3 (unculturedbacterium) | 5 / 12 | PHE A 95SER A 125GLY A 103GLY A 97ALA A 105 | NoneNoneNoneOAS A 169 ( 4.3A)None | 1.08A | 5kpcB-5jd5A:2.3 | 5kpcB-5jd5A:20.85 |